glp-1 weight loss drugs side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Peptide/GLP-1 Complications: 11 Hidden Risks
Description
Your healthcare provider can help determine the cause
GLP-1 Receptor Stimulation of the Lateral Parabrachial Nucleus Reduces Food Intake: Neuroanatomical, Electrophysiological, and Behavioral Evidence
Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
The reality is that for many people, obesity represents a biological condition that requires pharmacological management just like any other chronic disease
References New England Journal of Medicine
